MT1 | Bivalent inhibitor of BRD2, BRD4, BRD3, BRDT
RATINGS:
Cellular Use: (3 reviews)

In Model Organisms: (3 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
BRD2
    • IC50:0.170 nM
    • IC50:0.792 nM
    BRD4
    • Kd:16.7 nM
    • IC50:3.09 nM
    • IC50:0.170 nM
    • IC50:0.792 nM
    BRD3
      • IC50:0.170 nM
      • IC50:0.792 nM
      BRDT
      • IC50:1.32 nM
      • IC50:0.170 nM
      • IC50:0.792 nM
      0.1-100 nM

      Selectivity

      In Vitro Selectivity Assessment
      Potency Assay Off-Target:
      MT1 compound showed picomolar displacement of phage expressing: BRD2(1): 160 pM; BRD2(1,2): ...
      Selectivity Assessment Description:
      In ExpresSProfile (CEREP) MT1 showed negligible activity for over 50 ligand receptors, ion channe ...

      Potency
      Cellular
      In Vitro

      BRD2

      Mode of Action: Bivalent inhibitor

      Structure-Activity-Relationship data available? No

      DOI Reference: 10.1038/nchembio.2209

      BRD4

      Mode of Action: Bivalent inhibitor

      Structure-Activity-Relationship data available? No

      DOI Reference: 10.1038/nchembio.2209

      BRD3

      Mode of Action: Bivalent inhibitor

      Structure-Activity-Relationship data available? No

      DOI Reference: 10.1038/nchembio.2209

      BRDT

      Mode of Action: Bivalent inhibitor

      Structure-Activity-Relationship data available? No

      DOI Reference: 10.1038/nchembio.2209

      In Vivo Validations

      Mouse
      Dose: 50 mg/kg
      Route of delivery: Intraperitoneal
      Plasma half life: 2.70 hr

      DOI Reference: 10.1038/nchembio.2209

      Orthogonal Probes def

      Chemical Information

      Molecular Formula C54H66Cl2N10O9S2
      SMILEs Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCOCCOCCOCCOCCOCCNC(=O)C[C@@H]1N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc31)c1nnc(C)n1-2
      InChI InChI=1S/C54H66Cl2N10O9S2/c1-33-35(3)76-53-47(33)49(39-7-11-41(55)12-8-39)59-43(51-63-61-37(5)65(51)53)31-45(67)57-15-17-69-19-21-71-23-25-73-27-29-75-30-28-74-26-24-72-22-20-70-18-16-58-46(68)32-44-52-64-62-38(6)66(52)54-48(34(2)36(4)77-54)50(60-44)40-9-13-42(56)14-10-40/h7-14,43-44H,15-32H2,1-6H3,(H,57,67)(H,58,68)/t43-,44-/m0/s1
      Molecular weight 1132.38 Da
      AlogP 7.74152000000001
      HBond acceptors 19
      HBond donors 2
      Atoms 143

      Vendors

      Note: This is not an exhaustive list and does not indicate endorsement by the Portal.

      Expert Reviews


      (on 28 Nov 2016)
      Cellular Use Rating
      In Model Organisms
      This is a highly potent BET bromodomain inhibitor with more than 100-fold higher cellular potency than the corresponding monovalent antagonist JQ1. Potencies for the on-target proteins of the parent...
      (on 23 Dec 2016)
      Cellular Use Rating
      In Model Organisms
      MT1 is a bivalent BET bromodomain inhibitor, which is >100-fold more potent in the cell than the monovalent inhibitor JQ1. In a xenograpt model, MT1 treatment decreased tumor burden compared with JQ1....
      (on 20 Jan 2017)
      Cellular Use Rating
      In Model Organisms
      (The reviewer did not leave any public comments)
      If you would like to explore AI-generated evaluations, you may wish to visit the page for this compound on our collaborator website
      Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria